What Is An HAI?

Hospital-Acquired Infections (HAIs) are infections contracted inside a hospital facility. Typically, patients with compromised immune systems, such as cancer patients, newborns or the elderly, are the most likely to contract an HAI. These infections are the result of cross-contamination and 70% of them are resistant to antibiotics. On any given day, one in 25 patients has an HAI.

How Common Are HAI’s?

722,000 people suffer from HAIs in hospitals each year, which is 4% of all hospital admissions. 75,000 of those people die during hospitalization. In the past 20 years the overall incidence of HAIs has increased by 36% in the United States. A recent study in JAMA Internal Medicine found that almost 441,000 patients contract one of five HAIs each year, and about 50% of these infections are avoidable. In effect, HAIs are infecting a population the size of Atlanta every year.

How Do HAI’s Occur?

The short answer to this question is “cross-contamination.” However, that can happen in a variety of ways. The most common occurrences happen through central line-associated blood-stream infections (CLABSI), ventilator-associated infections (which can occur via surgical site infection (SSI)), catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia (VAP) and Clostridium difficile infections (CDI). Methicillin-resistant Staphylococcus aureus (MRSA) was added as a sub-category under SSIs and CLABSIs.

What Has Been Done to Stop HAI’s?

In 2009 the U.S. Department of Health and Human Services (HHS) developed the National Action Plan to help prevent Hospital-Acquired Infections. They set “reachable” HAI prevention goals. The plan was divided into three phases, each one focusing on a different type of healthcare facility. Goals included prioritizing the research agenda, integrating policy options for linking payment incentives/disincentives to quality of care, raising awareness of HAIs and enhancing regulatory oversight of hospitals. The CDC publishes an HAI progress report on a regular basis to update the public on the results of these goals. The CDC estimates that up to 70% of HAIs are preventable.

How Can HAI’s Be Stopped?

Antibiotic resistance is not going to go away anytime soon. So the best way to prevent the spread of HAIs is to avoid cross-contamination and kill harmful microorganisms at the source. Consistent and effective sanitization of primary fomites is key. One of the major issues in a lot of hospitals is compliance. Hospital employees are busy and stretched in many different directions and tasks like cleaning a keyboard can be put on the back burner.

Read On About UV-C Technology

Contact Us

425.318.7900

19201 120th Ave NE, Ste 200
Bothell, WA 98011

[email protected]

Learn More

If you have additional questions or would like for someone to contact you by phone or email, please fill out the form.

Blog

Best Practices for Recruiting During COVID

Even though we are in a pandemic, businesses must still hire for open roles. While pay and benefits are still important to candidates, in our COVID world, how you ensure your workplace is a safe and healthy environment now takes on greater significance for potential...

Getting Answers: efficacy and safety of UV-C disinfecting products

SPRINGFIELD, MA (WGGB/WSHM) -- As the world continues to grapple with the coronavirus pandemic, new products are being developed to disinfect surfaces in hopes of killing the coronavirus. UV-C products have quickly attracted buyers as an alternative to using...

The Best Protective Gear of 2020

One of the chief concerns of 2020 is “staying safe.” It’s been a tumultuous year that’s pushed everyone to show concern for their own health and the safety of those around them. A consistent difficulty for consumers is finding the right protective products, from masks...

This Product Is In High Demand

As COVID-19 continues to disrupt life around the globe, Vioguard is committed to providing high-quality disinfecting solutions to its customers. We recognize the essential role our UV-C sanitization devices play in killing pathogens and eliminating cross-contamination across medical, corporate and consumer environments. While we have ramped up production to address the current demand for our technologies, certain products may be in a “Back-Order” status.

If a product is marked “Back-Ordered”, it will ship when available. Based on current production schedules, we expect product shipments to commence the week of April 27, 2020. You may purchase a “Back-Ordered” product at any time, this will ensure prompt delivery once the product is available. If you have other products in your order that are available now, those products will ship immediately.

We thank you for your continued trust in our products and hope you remain safe and healthy during this challenging time.